AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 23 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,795,000 | -37.4% | 5,584,000 | -34.3% | 0.74% | -28.9% |
| Q1 2022 | $7,665,000 | +2.2% | 8,505,000 | -6.1% | 1.04% | +16.0% |
| Q4 2021 | $7,499,000 | +225.6% | 9,055,000 | +262.2% | 0.90% | +165.1% |
| Q3 2021 | $2,303,000 | -64.9% | 2,500,000 | -60.4% | 0.34% | -76.3% |
| Q1 2021 | $6,570,000 | -11.6% | 6,317,000 | -21.7% | 1.43% | +51.1% |
| Q4 2020 | $7,432,000 | – | 8,067,000 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
| PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
| DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
| Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
| DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
| Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
| Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
| Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |